Search Results - "Standop, Jens"

Refine Results
  1. 1

    Risk factors for delayed gastric emptying following distal pancreatectomy by Glowka, Tim R., von Websky, Martin, Pantelis, Dimitrios, Manekeller, Steffen, Standop, Jens, Kalff, Jörg C., Schäfer, Nico

    Published in Langenbeck's archives of surgery (01-03-2016)
    “…Purpose Delayed gastric emptying (DGE) is a frequent complication after pancreatoduodenectomy and other types of upper gastrointestinal surgery with published…”
    Get full text
    Journal Article
  2. 2
  3. 3

    State-of-the-art classification and multimodality treatment of malignant thymoma by Koppitz, Hannah, Rockstroh, Jürgen K, Schüller, Heinrich, Standop, Jens, Skowasch, Dirk, Müller-Hermelink, Hans Konrad, Schmidt-Wolf, Ingo G.H

    Published in Cancer treatment reviews (01-08-2012)
    “…Abstract Thymomas are the most common tumors of the anterior mediastinum. Classification, treatment options and understanding of the pathophysiology of thymoma…”
    Get full text
    Journal Article
  4. 4

    Prevention of Pancreatic Cancer Induction in Hamsters by Metformin by Schneider, Matthias B., Matsuzaki, Hosei, Haorah, James, Ulrich, Alexis, Standop, Jens, Ding, Xian-Zhong, Adrian, Thomas E., Pour, Parviz M.

    Published in Gastroenterology (New York, N.Y. 1943) (01-04-2001)
    “…Background & Aims: Our previous study suggested that the known promotional effect of a high fat diet, which in hamsters induces peripheral insulin resistance,…”
    Get full text
    Journal Article
  5. 5

    Parkinson’s disease influences the perioperative risk profile in surgery by Mueller, Marcus C., Jüptner, Ulf, Wuellner, Ullrich, Wirz, Stefan, Türler, Andreas, Hirner, Andreas, Standop, Jens

    Published in Langenbeck's archives of surgery (01-05-2009)
    “…Background and aims Aim of this study was to define the perioperative risk profile in surgery of patients suffering from Parkinson’s disease (PD) in order to…”
    Get full text
    Journal Article
  6. 6

    Perioperative management and outcome of general and abdominal surgery in hemophiliacs by Goldmann, Georg, M.D, Holoborodska, Yaroslava, M.S, Oldenburg, Johannes, M.D, Schaefer, Nico, M.D, Hoeller, Tobias, Ph.D, Standop, Jens, M.D, Kalff, Joerg C., M.D., F.A.C.S, Hirner, Andreas, M.D, Overhaus, Marcus, M.D

    Published in The American journal of surgery (01-05-2010)
    “…Abstract Background The aim of the current study was to investigate perioperative management and outcome of surgery in hemophiliacs. Methods Fifty-five…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Treatment and prognosis of gastric stump carcinoma in comparison with primary proximal gastric cancer by Schaefer, Nico, M.D, Sinning, Christoph, M.D, Standop, Jens, M.D, Overhaus, Marcus, M.D, Hirner, Andreas, M.D, Wolff, Martin, M.D

    Published in The American journal of surgery (01-07-2007)
    “…Abstract Background The intention of this study was to evaluate the outcome of patients with gastric stump cancer (GSC) in comparison with patients treated for…”
    Get full text
    Journal Article
  8. 8

    Leukotriene B4 Receptor Antagonist LY293111 Inhibits Proliferation and Induces Apoptosis in Human Pancreatic Cancer Cells by TONG, Wei-Gang, DING, Xian-Zhong, HENNIG, Rene, WITT, Richard C, STANDOP, Jens, POUR, Parviz M, ADRIAN, Thomas E

    Published in Clinical cancer research (01-10-2002)
    “…Purpose: The effects of leukotriene (LT) B4 and its receptorantagonist LY293111 on proliferation and apoptosis of human pancreatic cancer cells were…”
    Get full text
    Journal Article
  9. 9

    Combination of hypoxia and RNA-interference targeting VEGF induces apoptosis in hepatoma cells via autocrine mechanisms by Raskopf, Esther, Vogt, Annabelle, Decker, Georges, Hirt, Sarah, Daskalow, Katjana, Cramer, Thorsten, Standop, Jens, Gonzalez-Carmona, Maria-Angeles, Sauerbruch, Tilman, Schmitz, Volker

    Published in Current pharmaceutical biotechnology (01-09-2012)
    “…Control of VEGF signaling is an intense objective of pre-clinical and clinical studies in HCC disease with steadily increasing clinical application. Despite…”
    Get more information
    Journal Article
  10. 10

    Primary intrahepatic malignant mesothelioma of epithelioid type by GUTGEMANN, Ines, STANDOP, Jens, FISCHER, Hans-Peter

    “…A case of epithelioid mesothelioma presenting as a primary intrahepatic tumor is described. The patient was a 62-year-old man with a 5.8-cm intrahepatic mass…”
    Get full text
    Journal Article
  11. 11

    The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth by Nozawa, Fumiaki, Itami, Atsushi, Saruc, Murat, Kim, Min, Standop, Jens, Picha, Kathleen S, Cowan, Kenneth H, Pour, Parviz M

    Published in Pancreas (01-07-2004)
    “…Our previous studies have shown that, contrary to many other human pancreatic adenocarcinoma cell lines, AsPC1 cells are resistant to the apoptotic effect of…”
    Get full text
    Journal Article
  12. 12

    Expression of Nerve Growth Factors in Pancreatic Neural Tissue and Pancreatic Cancer by Schneider, Matthias B, Standop, Jens, Ulrich, Alexis, Wittel, Uwe, Friess, Helmut, Andren-Sandberg, Ake, Pour, Parviz M

    “…One of the characteristics of pancreatic cancer is its tendency to invade neural tissue. We hypothesized that the affinity of cancer cells for nerve tissue is…”
    Get full text
    Journal Article
  13. 13

    Combination of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and Actinomycin D Induces Apoptosis Even in TRAIL-resistant Human Pancreatic Cancer Cells by MATSUZAKI, Hosei, SCHMIED, Bruno M, ULRICH, Alexis, STANDOP, Jens, SCHNEIDER, Matthias B, BATRA, Surinder K, PICHA, Kathleen S, POUR, Parviz M

    Published in Clinical cancer research (01-02-2001)
    “…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a novel member of the tumor necrosis factor superfamily of cytokines that induces cell death…”
    Get full text
    Journal Article
  14. 14

    Multicenter Evaluation of A New Progastrin-releasing Peptide (ProGRP) Immunoassay across Europe and China by Korse, Catharina M, Holdenrieder, Stefan, Zhi, Xiuyi, Zahng, Xiaotong, Qiu, Ling, Geistanger, Andrea, Lisy, Marcus-Rene, Wehnl, Birgit, Broek, Daan van den, Escudero, José M, Standop, Jens, Hu, Mu, Molina, Rafael

    Published in Zhongguo fei ai za zhi (20-08-2017)
    “…背景 在欧洲和中国进行Elecsys®胃泌素释放肽前体(ProGRP)免疫检测的多中心评估研究。方法 在欧洲的3个中心和中国的2个中心,在肺癌中,通过不精密度、稳定性、方法学比较和鉴别诊断能力来评价该检测法。结果…”
    Get full text
    Journal Article
  15. 15

    Pancreatic cell lines: A review by ULRICH, Alexis B, SCHMIED, Bruno M, STANDOP, Jens, SCHNEIDER, Matthias B, POUR, Parviz M

    Published in Pancreas (01-03-2002)
    “…Pancreatic cancer has an extremely poor prognosis and lacks early diagnostic and therapeutic possibilities, mainly because of its silent course and explosive…”
    Get full text
    Journal Article
  16. 16

    Pancreatic enzyme extract improves survival in murine pancreatic cancer by Saruc, Murat, Standop, Silke, Standop, Jens, Nozawa, Fumiaki, Itami, Atsushi, Pandey, Krishan K, Batra, Surinder K, Gonzalez, Nicholas J, Guesry, Pierre, Pour, Parviz M

    Published in Pancreas (01-05-2004)
    “…The disappointing current therapeutic approaches for pancreatic cancer (PC) represent an urgent need for the development of novel methods to control the…”
    Get full text
    Journal Article
  17. 17

    Species Differences in the Distribution of Drug-Metabolizing Enzymes in the Pancreas by Ulrich, Alexis B., Standop, Jens, Schmied, Bruno M., Schneider, Matthias B., Lawson, Terence A., Pour, Parviz M.

    Published in Toxicologic pathology (01-03-2002)
    “…We investigated the cellular expression of 9 cytochrome P450-isozymes (CYP1A1, CYP1A2, CYP2B6, CYP2C8,9,19, CYP2D1, CYP2E1, CYP3A1, CYP3A2, CYP3A4) and 3…”
    Get full text
    Journal Article
  18. 18

    Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer by Standop, J, Schneider, M B, Ulrich, A, Pour, P M

    Published in Digestive diseases (Basel) (2001)
    “…The silent course of pancreatic cancer and its explosive fatal outcome have hindered studies of tumor histogenesis and the identification of early biochemical…”
    Get more information
    Journal Article
  19. 19

    Novel serum nucleosomics biomarkers for the detection of colorectal cancer by Holdenrieder, Stefan, Dharuman, Yoganiranjana, Standop, Jens, Trimpop, Nicolai, Herzog, Marielle, Hettwer, Karina, Simon, Kirsten, Uhlig, Steffen, Micallef, Jake

    Published in Anticancer research (01-05-2014)
    “…To improve prognosis of patients with colorectal cancer, powerful blood-based biomarkers enabling for early detection are needed. As genome-wide DNA…”
    Get full text
    Journal Article
  20. 20

    Differences in the expression of glutathione S-transferases in normal pancreas, chronic pancreatitis, secondary chronic pancreatitis, and pancreatic cancer by ULRICH, Alexis B, SCHMIED, Bruno M, STANDOP, Jens, SCHNEIDER, Matthias B, LAWSON, Terence A, FRIESS, Helmut, ANDREN-SANDBERG, Ake, BÜCHLER, Markus W, POUR, Parviz M

    Published in Pancreas (01-04-2002)
    “…In our previous study, glutathione S-transferase-pi (GST-pi), a phase II drug metabolizing enzyme, was found to be expressed in pancreatic ductal and ductular…”
    Get full text
    Journal Article